ArticleMMWR. Morbidity and mortality weekly report2020
Screening for Lung Cancer - 10 States, 2017.
Article in MMWR. Morbidity and mortality weekly report, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.
- LDCT uptake and determinants of lung cancer screening in Asia: a systematic review and meta-analysis.Frontiers in public health · 2025Pooled it
- Psychological Traits and the Persuasiveness of Lung Cancer Screening Health Messages.The Annals of thoracic surgery · 2022Trial
- Budget Impact of the LungFlag™ Predictive Risk Model for Lung Cancer Screening.PharmacoEconomics - open · 2026Article
- Project SWITCH Study Protocol: A Tobacco-Free Workplace Program for Dissemination and Implementation in Lung Cancer Screening Centers.Methods and protocols · 2025Article
- State and Regional Trends in Incidence and Early Detection of Lung Cancer Among US Adults, 2010-2020.Preventing chronic disease · 2024Article
- Computational and experimental microfluidics: Total analysis system for mixing, sorting, and concentrating particles and cells.APL bioengineering · 2024Article
- Characteristics of lung cancer screening eligible population in the US and prediction of the eligibility with simplified criteria.Translational cancer research · 2024Article
- Safety net hospital risk model demonstrates stronger, population-specific applicability in characterizing lung cancer risk.Translational cancer research · 2024Article
- Acceptability of Personalized Lung Cancer Screening Program Among Primary Care Providers.Cancer prevention research (Philadelphia, Pa.) · 2024Article
- Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium.Journal of general internal medicine · 2024Observational
- The aggregate value of cancer screenings in the United States: full potential value and value considering adherence.BMC health services research · 2023Article
- Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.Chest · 2023Article
- Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation.Respiratory research · 2023Article
- Observational
- Lung Cancer Screening Among U.S. Military Veterans by Health Status and Race and Ethnicity, 2017-2020: A Cross-Sectional Population-Based Study.AJPM focus · 2023Article
- Article
- Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer.Cancers · 2023Review
- A narrative review of lung cancer screening in underserved populations.Current challenges in thoracic surgery · 2023Article
- Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.Translational behavioral medicine · 2022Article
- Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.JAMA network open · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer is the leading cause of cancer death in the United States; 148,869 lung cancer-associated deaths occurred in 2016 (1). Mortality might be reduced by identifying lung cancer at an early stage when treatment can be more effective (2). In 2013, the U.S. Preventive Services Task Force (USPSTF) recommended annual screening for lung cancer with low-dose computed tomography (CT) for adults aged 55-80 years who have a 30 pack-year* smoking history and currently smoke or have quit within the past 15 years (2).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.